Abstract:Abstract Lung cancer is one of the most common malignant tumors with high mortality worldwide. Recently, researchers reported that molecular markers on lung cancer could be used as diagnostic and prognostic targets. However, these molecules were not ideal in specificity and high selectivity. Therefore, exploring more reliable biomarkers to improve the prognosis and clarify the underlying mechanism is urgently needed both for clinic and basic research. This study aimed to identify significant genes with poor prediction for lung cancer and their underlying mechanisms. Firstly, we used gene expression datasets available from GEO (Gene Expression Omnibus) database. There were 109 lung cancer samples and 27 normal samples in the selected datasets. First, DEGs (Different Expressed Gene set) of lung cancer and normal lung samples were screen out with GEO2R tool, and we displayed them by Venn diagram software and Heatmap. Secondly, we used DAVID (Database for Annotation, Visualization and Integrated Discovery) to analyze KEGG (Kyoto Encyclopedia of Gene and Genome) pathway and GO (Gene Ontology). Third, PPI (Protein-Protein Interaction) of these DEGs was conducted by Cytoscape with STRING (Search Tool for the Retrieval of Interacting Genes). Our results showed that the expression trends of 21 up-regulated genes and 116 down-regulated were similar in selected three datasets. Analyzed by MCODE (Molecular Complex Detection) plug-in, 11 up-regulated and 16 down-regulated genes were selected. To further verify gene expression differences, GEPIA (Gene Expression Profiling Interactive Analysis) was implemented and we found 26 of 27 genes were found differently expressed in lung cancer compared with normal lung tissues. Furthermore, Kaplan–Meier analysis was used and we found 23 of 26 genes for overall survival indicated much less survival time. At last, three genes, CDH5, CLDN5, PECAM1, were found to be significantly decreased in lung cancer tissue proved through re-analysis of DAVID, which mainly co-related with leukocyte trans-endothelial migration. In conclusion, three significant down-regulated deferentially expressed genes with poor prognosis on lung cancer were identified basing on integrated bioinformatical methods. These down-expressed genes may be as a potential prognosis targets for patients with lung cancer.

Decreased Expression of Decorin and P57(Kip2) Correlates with Poor Survival and Lymphatic Metastasis in Lung Cancer Patients

P57(Kip2) Expression is Related to Carcinogenesis and Tumor Progression in Laryngeal Tissues

Study on expressions of Decorin mRNA、 p57~(KIP2) mRNA and TGF-β1 and their clinical significance in lung cancer

Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I–IIIA non-small cell lung cancer

Podoplanin-positive Cancer-Associated Fibroblasts Predict Poor Prognosis in Lung Cancer Patients

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Decorin is Responsible for Progression of Non-Small-cell Lung Cancer by Promoting Cell Proliferation and Metastasis

Human decorin regulates proliferation and migration of human lung cancer A549 cells.

Expression of Decorin in Cholangiocarcinoma and Clinical Implication

Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling

High Skp2/Low p57 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

High Skp2/Low P57kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

Expression and Correlations of Survivin、VEGF and P53 in Lung Squamous Cell Cacinomas and Adenocarcinomas

Expression and Clinical Significance of Survivin and Its Correlation with P53 in Lung Squamous Cell Cacinomas and Adenocarcinomas

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis

Genes co-related with poor prognosis of patients with lung cancer via bioinformatical approaches

Mechanism of Decorin Protein Inhibiting Invasion and Metastasis of Non-Small Cell Lung Cancer.

Decorin As a Prognostic Biomarker in Patients with Malignant Peripheral Nerve Sheath Tumors.

Expression of Survivin, PTEN and BFGF in Lung Cancer Progression Tissue Microarray

The expression of CD147 and PTEN in non small cell lung cancer and their correlation with clinical pathological factors

Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters.